Nawras Ali, Alsolaiman Mohammad M, Mehboob Shahid, Bartholomew Catherine, Maliakkal Benedict
Department of Gastroenterology, Albany Medical College, New York 12208, USA.
Dig Dis Sci. 2002 Jul;47(7):1627-31. doi: 10.1023/a:1015843908536.
Sarcoidosis is a multisystem granulomatous disease of unknown etiology. Immune alterations involving heightened T-helper-1 responses have been proposed to play a major role in the pathogenesis of sarcoidosis. Interferon-alpha therapy and hepatitis C infection have been implicated in the development of a variety of autoimmune diseases. However, despite the wide use of IFN-alpha therapy for hepatitis C, only a few cases of sarcoidosis have been reported in this context. We report the case of a 42-year-old white female with hepatitis C, who developed systemic sarcoidosis shortly after therapy with IFN-alpha2b. The disease was heralded by the appearance of a cutaneous sarcoid/ foreign body granulomatous reaction at the site of an old tattoo. The sarcoidosis responded to a short course of oral prednisone therapy. We also reviewed the other reported cases and discussed the possible immunological mechanisms involved.
结节病是一种病因不明的多系统肉芽肿性疾病。有观点认为,涉及辅助性T细胞1型反应增强的免疫改变在结节病的发病机制中起主要作用。α干扰素治疗和丙型肝炎感染与多种自身免疫性疾病的发生有关。然而,尽管α干扰素疗法广泛用于治疗丙型肝炎,但在此背景下仅报告了少数结节病病例。我们报告了一例42岁的丙型肝炎白人女性病例,该患者在接受α干扰素2b治疗后不久就出现了系统性结节病。该病以旧纹身部位出现皮肤结节病/异物肉芽肿反应为先兆。该结节病对短期口服泼尼松治疗有反应。我们还回顾了其他报告的病例,并讨论了可能涉及的免疫机制。